BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Korea University

Headquarters: Seoul, South Korea
Year Founded: 1905
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Sep 26, 2024
Discovery & Translation

Science Spotlight: Targeted protein relocalization, rejuvenating aged eggs, and more

BioCentury’s roundup of translational innovations
BioCentury | Aug 19, 2023
Discovery & Translation

PROTAC using an alt. E3 ligase; plus lung-targeted mRNA COVID vaccine and more

BioCentury’s roundup of translational innovations
BioCentury | Oct 1, 2021
Distillery Therapeutics

Improving base editing with recombinant editor proteins

BioCentury | Jul 25, 2019
Tools & Techniques

New CRISPR case to finally settle the score

How the latest interference between Broad and UC could shake up the landscape of CRISPR therapies
BioCentury | Oct 4, 2018
Tools & Techniques

No crisp upper hand in CRISPR

What the most recent CRISPR ruling means for companies looking to access the IP
BioCentury | Sep 26, 2018
Distillery Therapeutics

Cancer

BioCentury | Apr 13, 2018
Targets & Mechanisms

Hello RNA

New targets at AACR suggest non-coding RNAs are on the rise
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

Direct evidence of necroptosis in Alzheimer's
BioCentury | Aug 9, 2017
Distillery Therapeutics

Cancer

BioCentury | Aug 3, 2017
Tools & Techniques

The other side of the Rubicon

Embryo study’s success is shifting the topic from ethics to efficacy
Items per page:
1 - 10 of 24